title: CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.
abstract: Human CYP2B6 has been thought to account for a minor portion (<1%) of total hepatic cytochrome P450 (CYP) content and to have a minor function in human drug metabolism. Recent studies, however, indicate that the average relative contribution of CYP2B6 to total hepatic CYP content ranges from 2% to 10%. An increased interest in CYP2B6 research has been stimulated by the identification of an ever-increasing substrate list for this enzyme, polymorphic and ethnic variations in expression levels, and evidence for cross-regulation with CYP3A4, UGT1A1 and several hepatic drug transporters by the nuclear receptors pregnane X receptor and constitutive androstane receptor. Moreover, 20- to 250-fold interindividual variation in CYP2B6 expression has been demonstrated, presumably due to transcriptional regulation and polymorphisms. These individual differences may result in variable systemic exposure to drugs metabolized by CYP2B6, including the antineoplastics cyclophosphamide and ifosfamide, the antiretrovirals nevirapine and efavirenz, the anesthetics propofol and ketamine, the synthetic opioid methadone, and the anti-Parkinsonian selegiline. The potential clinical significance of CYP2B6 further enforces the need for a comprehensive review of this xenobiotic metabolizing enzyme. This communication summarizes recent advances in our understanding of this traditionally neglected enzyme and provides an overall picture of CYP2B6 with respect to expression, localization, substrate-specificity, inhibition, regulation, polymorphisms and clinical significance. Emphasis is given to nuclear receptor mediated transcriptional regulation, genetic polymorphisms, and their clinical significance.
authors.affiliation: Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, 20 Penn Street, Baltimore, MD 21201, USA. hwang@rx.umaryland.edu
authors.forename: Hongbing
authors.initials: H
authors.lastname: Wang
authors.forename: Leslie M
authors.initials: LM
authors.lastname: Tompkins
mesh_terms: D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D065702:Cytochrome P-450 CYP2B6; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D010089:Oxidoreductases, N-Demethylating / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D020218:Response Elements
chemical_list: D018160:Receptors, Cytoplasmic and Nuclear; D001189:Aryl Hydrocarbon Hydroxylases; C585599:CYP2B6 protein, human; D065702:Cytochrome P-450 CYP2B6; D010089:Oxidoreductases, N-Demethylating
references.citation: Nucleic Acids Res. 1990 Jul 25;18(14):4237-42
references.pmid: 2377462
references.citation: Drug Metab Dispos. 1993 Nov-Dec;21(6):1048-56
references.pmid: 7905383
references.citation: Breast Cancer Res Treat. 1993;26 Suppl:S11-7
references.pmid: 8400329
references.citation: Mol Pharmacol. 2008 Apr;73(4):1122-33
references.pmid: 18212249
references.citation: Pharmacogenomics. 2008 Jan;9(1):71-83
references.pmid: 18154449
references.citation: J Pharmacol Exp Ther. 2007 Jan;320(1):72-80
references.pmid: 17041008
references.citation: Pharmacogenetics. 1997 Oct;7(5):381-90
references.pmid: 9352574
references.citation: Drug Metab Dispos. 2000 Feb;28(2):110-2
references.pmid: 10640505
references.citation: Pharmacogenet Genomics. 2007 Jun;17(6):431-45
references.pmid: 17502835
references.citation: Clin Infect Dis. 2006 Feb 1;42(3):408-10
references.pmid: 16392090
references.citation: Nature. 2000 Oct 19;407(6806):920-3
references.pmid: 11057673
references.citation: Comp Biochem Physiol C Toxicol Pharmacol. 2002 Apr;131(4):501-10
references.pmid: 11976065
references.citation: Drug Metab Dispos. 2000 Oct;28(10):1222-30
references.pmid: 10997944
references.citation: Mol Cell Biol. 1999 Sep;19(9):6318-22
references.pmid: 10454578
references.citation: Biochem Biophys Res Commun. 2006 Aug 25;347(2):485-95
references.pmid: 16828057
references.citation: Pharmacogenetics. 2004 Jan;14(1):1-18
references.pmid: 15128046
references.citation: J Clin Pharmacol. 2008 Apr;48(4):464-74
references.pmid: 18287571
references.citation: Xenobiotica. 1996 Nov;26(11):1155-66
references.pmid: 8948091
references.citation: Drug Metab Dispos. 2004 Sep;32(9):930-6
references.pmid: 15319333
references.citation: Clin Pharmacol Ther. 2003 Jul;74(1):32-43
references.pmid: 12844133
references.citation: Xenobiotica. 1999 Feb;29(2):187-93
references.pmid: 10199594
references.citation: J Biol Chem. 2001 May 4;276(18):14581-7
references.pmid: 11297522
references.citation: Proc Natl Acad Sci U S A. 1983 Jul;80(13):3958-62
references.pmid: 6306654
references.citation: Eur J Pharm Sci. 2001 Jul;13(4):343-68
references.pmid: 11408150
references.citation: J Biol Chem. 2008 Apr 18;283(16):10425-32
references.pmid: 18303024
references.citation: Drug Metab Dispos. 2003 Apr;31(4):439-46
references.pmid: 12642470
references.citation: Drug Metab Dispos. 1999 Nov;27(11):1309-18
references.pmid: 10534317
references.citation: Clin Pharmacokinet. 2003;42(15):1331-57
references.pmid: 14674787
references.citation: Mol Cell. 2004 Dec 22;16(6):893-905
references.pmid: 15610733
references.citation: Mol Pharmacol. 2006 Dec;70(6):1925-34
references.pmid: 16988011
references.citation: Cancer Lett. 2008 Jan 18;259(1):1-15
references.pmid: 18053638
references.citation: Mol Pharmacol. 2002 Sep;62(3):638-46
references.pmid: 12181440
references.citation: Curr Drug Metab. 2005 Aug;6(4):369-83
references.pmid: 16101575
references.citation: Clin Infect Dis. 2006 Feb 1;42(3):401-7
references.pmid: 16392089
references.citation: Mol Cell Biol. 1998 Oct;18(10):5652-8
references.pmid: 9742082
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1045-50
references.pmid: 17213310
references.citation: Toxicology. 1998 Nov 2;131(1):9-20
references.pmid: 9881931
references.citation: Pharmacogenetics. 1996 Feb;6(1):1-42
references.pmid: 8845856
references.citation: Proc Natl Acad Sci U S A. 1982 May;79(9):2793-7
references.pmid: 6953431
references.citation: J Biol Chem. 2001 Oct 12;276(41):37739-42
references.pmid: 11459851
references.citation: Neuropharmacology. 2003 Jul;45(1):122-32
references.pmid: 12814665
references.citation: Biol Pharm Bull. 2000 Apr;23(4):498-501
references.pmid: 10784435
references.citation: Curr Drug Metab. 2003 Dec;4(6):515-25
references.pmid: 14683479
references.citation: Clin Pharmacol Ther. 2007 May;81(5):719-28
references.pmid: 17329992
references.citation: J Biochem Mol Toxicol. 2005;19(2):96-108
references.pmid: 15849716
references.citation: Ann Hum Genet. 1985 Oct;49(4):267-74
references.pmid: 3000277
references.citation: Biochem J. 1992 Jan 15;281 ( Pt 2):359-68
references.pmid: 1736885
references.citation: Clin Infect Dis. 2007 Nov 1;45(9):1230-7
references.pmid: 17918089
references.citation: Mol Cell Biol. 2000 May;20(9):2951-8
references.pmid: 10757780
references.citation: Pharmacogenetics. 2001 Jul;11(5):399-415
references.pmid: 11470993
references.citation: Pharmacogenet Genomics. 2005 Jan;15(1):1-5
references.pmid: 15864119
references.citation: Mol Pharmacol. 2000 Dec;58(6):1441-50
references.pmid: 11093784
references.citation: Br J Clin Pharmacol. 1999 Oct;48(4):528-35
references.pmid: 10583023
references.citation: Biochem Pharmacol. 2001 Jul 15;62(2):161-9
references.pmid: 11389874
references.citation: J Clin Invest. 1992 Nov;90(5):1871-8
references.pmid: 1430211
references.citation: Drug Metab Rev. 1999 Aug;31(3):719-54
references.pmid: 10461547
references.citation: J Biol Chem. 2000 May 19;275(20):15122-7
references.pmid: 10748001
references.citation: Drug Metab Dispos. 2002 Dec;30(12):1400-5
references.pmid: 12433810
references.citation: J Biochem Mol Toxicol. 2007;21(2):76-80
references.pmid: 17427179
references.citation: J Biol Chem. 2005 Feb 4;280(5):3458-66
references.pmid: 15563456
references.citation: Drug Metab Dispos. 2002 Jul;30(7):814-22
references.pmid: 12065440
references.citation: Drug Metab Dispos. 2003 May;31(5):620-30
references.pmid: 12695351
references.citation: Rinsho Ketsueki. 2002 Jun;43(6):482-7
references.pmid: 12134706
references.citation: Drug Metab Dispos. 2007 Nov;35(11):2053-9
references.pmid: 17682072
references.citation: Pharmacogenomics. 2007 Jun;8(6):547-58
references.pmid: 17559344
references.citation: Pharmacogenet Genomics. 2005 Dec;15(12):861-73
references.pmid: 16272958
references.citation: J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42
references.pmid: 17786128
references.citation: Drug Metab Dispos. 1997 Aug;25(8):985-93
references.pmid: 9280407
references.citation: Drug Metab Rev. 2002 Feb-May;34(1-2):83-448
references.pmid: 11996015
references.citation: Nucleic Acids Res. 2003 Jun 15;31(12):3194-207
references.pmid: 12799447
references.citation: J Biol Chem. 2004 Jul 9;279(28):29295-301
references.pmid: 15123723
references.citation: J Pharmacol Exp Ther. 2008 Apr;325(1):284-92
references.pmid: 18171905
references.citation: Mol Pharmacol. 2002 Sep;62(3):737-46
references.pmid: 12181452
references.citation: Curr Drug Metab. 2003 Feb;4(1):59-72
references.pmid: 12570746
references.citation: Clin Pharmacokinet. 2005;44(11):1135-64
references.pmid: 16231966
references.citation: Pharm Res. 2006 Sep;23(9):1983-90
references.pmid: 16951995
references.citation: Gene. 1995 Jun 9;158(2):263-8
references.pmid: 7607552
references.citation: Annu Rev Pharmacol Toxicol. 2001;41:123-43
references.pmid: 11264453
references.citation: Br J Clin Pharmacol. 2007 Sep;64(3):391-5
references.pmid: 17391322
references.citation: Chirality. 2004 Jan;16(1):36-44
references.pmid: 14628297
references.citation: AIDS. 2004 Dec 3;18(18):2391-400
references.pmid: 15622315
references.citation: Mol Pharmacol. 2005 May;67(5):1772-82
references.pmid: 15722458
references.citation: Cancer Res. 1993 Dec 1;53(23):5629-37
references.pmid: 8242617
references.citation: Mol Genet Metab. 2005 Sep-Oct;86(1-2):314-9
references.pmid: 15990349
references.citation: Eur J Pharm Sci. 2005 Jan;24(1):123-32
references.pmid: 15626586
references.citation: Mol Pharmacol. 2005 Jun;67(6):1954-65
references.pmid: 15761118
references.citation: Cell Biol Toxicol. 2007 Mar;23(2):63-73
references.pmid: 16964586
references.citation: Eur J Clin Pharmacol. 2006 Jul;62(7):585-6
references.pmid: 16770645
references.citation: Anesthesiology. 1995 Jan;82(1):214-20
references.pmid: 7832304
references.citation: Pharmacogenomics J. 2005;5(1):6-13
references.pmid: 15492763
references.citation: Pediatr Nephrol. 2005 Jul;20(7):872-85
references.pmid: 15875221
references.citation: J Biol Chem. 2005 Feb 11;280(6):4367-73
references.pmid: 15572372
references.citation: Mol Pharmacol. 2005 Nov;68(5):1239-53
references.pmid: 16099843
references.citation: Nature. 1998 Oct 8;395(6702):612-5
references.pmid: 9783588
references.citation: Drug Metab Dispos. 1994 Nov-Dec;22(6):937-46
references.pmid: 7895613
references.citation: Toxicol Sci. 2006 Dec;94(2):261-71
references.pmid: 16945988
references.citation: J Biochem Mol Toxicol. 1998;12(1):3-9
references.pmid: 9414482
references.citation: Anesthesiology. 2001 Jan;94(1):110-9
references.pmid: 11135730
references.citation: Drug Metab Dispos. 2001 Jun;29(6):887-90
references.pmid: 11353758
references.citation: J Biol Chem. 2001 Apr 20;276(16):12822-6
references.pmid: 11278292
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4156-61
references.pmid: 12644704
references.citation: Eur J Pharm Sci. 2006 Jan;27(1):54-61
references.pmid: 16183265
references.citation: Drug Metab Dispos. 2001 Jan;29(1):36-40
references.pmid: 11124227
references.citation: Drug Metab Dispos. 2002 Dec;30(12):1329-36
references.pmid: 12433799
references.citation: Biochem Soc Trans. 1990 Dec;18(6):1202
references.pmid: 2088865
references.citation: J Biol Chem. 2003 Apr 18;278(16):14146-52
references.pmid: 12571232
references.citation: J Pharmacol Exp Ther. 1994 Jul;270(1):414-23
references.pmid: 8035341
references.citation: Mol Endocrinol. 2004 Jul;18(7):1589-98
references.pmid: 14988430
references.citation: Curr HIV/AIDS Rep. 2006 Jul;3(2):53-8
references.pmid: 16608660
references.citation: Science. 2001 Jun 22;292(5525):2329-33
references.pmid: 11408620
references.citation: J Biol Chem. 1996 Apr 19;271(16):9746-53
references.pmid: 8621653
references.citation: Ann Hum Genet. 1988 May;52(2):129-35
references.pmid: 3248006
references.citation: Clin Pharmacol Ther. 2006 Jul;80(1):75-84
references.pmid: 16815319
references.citation: Biochem Pharmacol. 2000 Apr 15;59(8):961-72
references.pmid: 10692561
references.citation: J Biol Chem. 1996 Sep 27;271(39):23725-8
references.pmid: 8798596
references.citation: Biochemistry. 1989 Sep 5;28(18):7340-8
references.pmid: 2573390
references.citation: Biochem Pharmacol. 1993 Mar 24;45(6):1251-9
references.pmid: 8466546
references.citation: Hum Genomics. 2005 Sep;2(3):196-201
references.pmid: 16197738
references.citation: Mol Pharmacol. 1993 Oct;44(4):775-83
references.pmid: 8232228
references.citation: J Biochem Mol Toxicol. 2000;14(4):177-88
references.pmid: 10789495
references.citation: Pharmacogenomics. 2007 Jul;8(7):743-59
references.pmid: 17638512
references.citation: Cancer Res. 2004 Jan 1;64(1):292-303
references.pmid: 14729637
references.citation: Biol Pharm Bull. 2005 Sep;28(9):1711-6
references.pmid: 16141545
references.citation: Drug Metab Dispos. 1999 Dec;27(12):1488-95
references.pmid: 10570031
references.citation: Toxicology. 1996 Apr 30;108(3):185-90
references.pmid: 8658537
references.citation: Mol Pharmacol. 2003 Jul;64(1):160-9
references.pmid: 12815172
references.citation: Arch Biochem Biophys. 2000 Apr 1;376(1):206-16
references.pmid: 10729207
references.citation: Br J Clin Pharmacol. 2002 Aug;54(2):157-67
references.pmid: 12207635
references.citation: J Biol Chem. 1999 Mar 5;274(10):6043-6
references.pmid: 10037683
references.citation: Clin Pharmacol Ther. 1996 Jun;59(6):613-23
references.pmid: 8681486
references.citation: Hepatology. 2001 May;33(5):1232-8
references.pmid: 11343253
references.citation: Mol Pharmacol. 2001 Sep;60(3):427-31
references.pmid: 11502872
references.citation: Carcinogenesis. 1994 Jan;15(1):5-9
references.pmid: 8293548
references.citation: Biochem Biophys Res Commun. 2004 Jul 9;319(4):1322-6
references.pmid: 15194512
references.citation: Drug Metab Dispos. 2004 Jan;32(1):35-42
references.pmid: 14709618
references.citation: J Biol Chem. 2006 Sep 8;281(36):26540-51
references.pmid: 16825189
references.citation: Clin Pharmacol Ther. 2004 Sep;76(3):250-69
references.pmid: 15371986
references.citation: Alcohol Clin Exp Res. 1999 Jun;23(6):991-1007
references.pmid: 10397283
references.citation: Mol Cell. 2004 Dec 22;16(6):907-17
references.pmid: 15610734
references.citation: Biochem Biophys Res Commun. 2000 Oct 14;277(1):1-6
references.pmid: 11027630
references.citation: Drug Metab Dispos. 1999 Apr;27(4):517-25
references.pmid: 10101147
references.citation: Annu Rev Pharmacol Toxicol. 2003;43:149-73
references.pmid: 12171978
references.citation: Hepatology. 2004 Oct;40(4):951-60
references.pmid: 15382119
references.citation: Drug Metab Dispos. 2004 Jun;32(6):626-31
references.pmid: 15155554
references.citation: Drug Metab Dispos. 1999 Dec;27(12):1429-33
references.pmid: 10570024
references.citation: J Pharmacol Exp Ther. 2004 Oct;311(1):34-43
references.pmid: 15190123
references.citation: J Clin Pharmacol. 2006 Dec;46(12):1426-38
references.pmid: 17101742
references.citation: Anesthesiology. 1995 Mar;82(3):689-99
references.pmid: 7879937
references.citation: J Pharmacol Exp Ther. 2006 Jun;317(3):1200-9
references.pmid: 16513849
references.citation: Drug Metab Dispos. 2001 Oct;29(10):1325-31
references.pmid: 11560876
references.citation: J Biol Chem. 1983 Jul 10;258(13):8081-5
references.pmid: 6408085
references.citation: Biochem J. 2006 Aug 15;398(1):125-33
references.pmid: 16623664
references.citation: Biochem Pharmacol. 1998 May 15;55(10):1633-40
references.pmid: 9633999
references.citation: Pharmacol Ther. 2007 Feb;113(2):420-8
references.pmid: 17157385
references.citation: Drug Metab Dispos. 1999 Jun;27(6):655-66
references.pmid: 10348794
references.citation: Drug Metab Dispos. 2002 Jul;30(7):853-8
references.pmid: 12065445
references.citation: Drug Metab Dispos. 2004 Mar;32(3):348-58
references.pmid: 14977870
references.citation: Neuropharmacology. 2006 Mar;50(4):441-50
references.pmid: 16309716
references.citation: Clin Pharmacol Ther. 2007 Apr;81(4):557-66
references.pmid: 17235330
references.citation: Br J Clin Pharmacol. 2001 Mar;51(3):281-5
references.pmid: 11298076
references.citation: Cell Mol Life Sci. 2001 May;58(5-6):737-47
references.pmid: 11437235
references.citation: Xenobiotica. 2003 Jan;33(1):13-25
references.pmid: 12519691
references.citation: Pharmacogenetics. 2004 Apr;14(4):225-38
references.pmid: 15083067
references.citation: Mol Pharmacol. 1998 Apr;53(4):597-601
references.pmid: 9547348
references.citation: J Pharmacol Exp Ther. 1998 Sep;286(3):1253-9
references.pmid: 9732386
references.citation: AIDS. 2001 Jan 5;15(1):71-5
references.pmid: 11192870
references.citation: Steroids. 2007 Mar;72(3):231-46
references.pmid: 17284330
references.citation: Biochem Pharmacol. 2001 Sep 15;62(6):777-86
references.pmid: 11551524
references.citation: J Pharmacol Exp Ther. 2003 Jul;306(1):287-300
references.pmid: 12676886
references.citation: J Biol Chem. 2003 May 9;278(19):17277-83
references.pmid: 12611900
references.citation: Drug Metab Dispos. 2000 Oct;28(10):1176-83
references.pmid: 10997936
references.citation: J Pharmacol Exp Ther. 2003 Dec;307(3):906-22
references.pmid: 14551287
references.citation: Carcinogenesis. 1997 Jan;18(1):207-14
references.pmid: 9054608
references.citation: Drug Metab Dispos. 2003 Sep;31(9):1093-102
references.pmid: 12920164
references.citation: Biochem Pharmacol. 1996 Apr 26;51(8):1041-50
references.pmid: 8866826
references.citation: Curr Drug Metab. 2005 Aug;6(4):329-39
references.pmid: 16101572
references.citation: J Biol Chem. 1998 Apr 3;273(14):8528-36
references.pmid: 9525968
references.citation: J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):551-6
references.pmid: 16044006
references.citation: Curr Drug Metab. 2006 May;7(4):397-409
references.pmid: 16724929
references.citation: Pharmacogenetics. 1999 Jun;9(3):295-306
references.pmid: 10471061
references.citation: Drug Metab Dispos. 2002 Sep;30(9):1035-42
references.pmid: 12167570
references.citation: Pharmacogenomics J. 2003;3(1):53-61
references.pmid: 12629583
references.citation: Drug Metab Dispos. 2001 Nov;29(11):1480-4
references.pmid: 11602525
references.citation: Drug Metab Dispos. 1997 Dec;25(12):1383-8
references.pmid: 9394028